ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

ARTL Artelo Biosciences Inc

1.25
-0.09 (-6.72%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Artelo Biosciences Inc ARTL NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.09 -6.72% 1.25 18:53:17
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.36 1.3109 1.36 1.3399 1.34
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
23/4/202407:30GLOBEArtelo Biosciences Announces Publication of Peer-Reviewed..
22/4/202407:30GLOBEArtelo Biosciences CEO to Appear on Benzinga All Access on..
25/3/202407:00GLOBEArtelo Biosciences Reports Fiscal 2023 Year-End Financial..
12/3/202408:15GLOBEArtelo Biosciences Selected as a Finalist in Johnson &..
23/1/202407:30GLOBEArtelo Biosciences Announces Publication of New..
08/1/202407:30GLOBEArtelo Biosciences Announces Selection of Worldwide Clinical..
05/12/202307:30GLOBEArtelo Biosciences Presents New Preclinical Data on ART12.11..
30/11/202308:00GLOBEArtelo Biosciences to Present Important New Preclinical Data..
13/11/202307:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202307:00GLOBEArtelo Biosciences Reports Third Quarter 2023 Financial..
09/11/202308:00GLOBEArtelo Biosciences Announces Publication of New..
02/11/202307:30GLOBEArtelo Biosciences to Present Preclinical Data Showcasing..
04/10/202307:30GLOBEPrincipal Investigator of Artelo’s CAReS Trial to..
13/9/202307:30GLOBEArtelo Biosciences to Present at the 13th Congress of the..
07/9/202307:00GLOBEArtelo Biosciences Completes Positive Pre-IND Meeting with..
06/9/202308:00GLOBEArtelo Biosciences to Present at the 6th Cannabinoid-Derived..
05/9/202308:00GLOBEArtelo Biosciences to Present at the H.C. Wainwright 25th..
10/8/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202307:00GLOBEArtelo Biosciences Reports Second Quarter 2023 Financial..
08/8/202315:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202315:34EDGAR2Form 8-K - Current report
19/7/202308:00GLOBEArtelo Biosciences to Present New Mechanism of Action Data..
16/7/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
10/7/202307:30GLOBEArtelo Biosciences CEO to Participate in the Benzinga All..
07/7/202307:23EDGAR2Form DEL AM - Delaying amendment
06/7/202315:31EDGAR2Form S-3 - Registration statement under Securities Act of..
03/7/202313:15EDGAR2Form 8-K - Current report
03/7/202313:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202307:30GLOBEArtelo Biosciences Announces Sponsorship of The William A...
27/6/202307:30GLOBEArtelo Biosciences Announces Important New Data on ART26.12..
26/6/202307:30GLOBEArtelo Biosciences Reports Superior Preclinical..
07/6/202307:30GLOBEArtelo Biosciences Selected for Oral Presentation to Report..
11/5/202307:00GLOBEArtelo Biosciences Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock